Spinocerebellar Ataxia Type 4 Overview
Learn About Spinocerebellar Ataxia Type 4
- Spinocerebellar ataxia 4
- SCA4
- Spinocerebellar ataxia autosomal dominant with sensory axonal neuropathy
- Spinocerebellar ataxia type 4
Northwestern Medical Faculty Foundation
Puneet Opal is a Neurologist in Chicago, Illinois. Dr. Opal has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. His top areas of expertise are Spinocerebellar Ataxia Type 1, Giant Axonal Neuropathy, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.
Select Rehabilitation LLC
Thomas Vaughan is an Internal Medicine provider in Glenview, Illinois. Dr. Vaughan has been practicing medicine for over 44 years and is rated as an Advanced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. His top areas of expertise are High Cholesterol, Sitosterolemia, Periventricular Heterotopia, and Cortical Dysplasia. Dr. Vaughan is currently accepting new patients.
Advocate Medical Group Primary Care - Ballard Road
Brian Rubenstein is a Geriatrics specialist and an Internal Medicine provider in Park Ridge, Illinois. Dr. Rubenstein and is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 4. His top areas of expertise are Memory Loss, Spinocerebellar Ataxia Type 5, Spinocerebellar Ataxia Type 12, and Spinocerebellar Ataxia Type 2. Dr. Rubenstein is currently accepting new patients.
Background: Spinocerebellar ataxia type 7 (SCA7) is a disease in which people have problems with coordination, balance, speech and vision. It is caused by a change in the ATXN7 gene. A mutation in this ATXN7 gene causes changes in eye cells, which can lead to vision loss. There is no cure for SCA7 but researchers are looking for possible treatments. Researchers need more information about SCA7. They want to c...
Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center